EX-99.1 2 drr0150_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

Dr. Reddy's Laboratories Ltd.
8-2-337, Road No. 3, Banjara Hills,
Hyderabad - 500 034, Telangana,
India.
CIN : L85195TG1984PLC004507
 
Tel      :+91 40 4900 2900
Fax     :+91 40 4900 2999
Email :mail@drreddys.com
www.drreddys.com

 

August 9, 2019

 

Corporate Relationship Department National Stock Exchange of India Ltd.
BSE Limited “Exchange Plaza”
Dalal Street, Fort Bandra-Kurla Complex, Bandra (East),
Mumbai – 400 001 Mumbai – 400 051
Fax Nos.: 022-22723121 / 22723719 Fax Nos.: 022-26598120/ 26598237

 

Scrip Code: 500124 Scrip Code: DRREDDY-EQ

 

Dear Sirs,

Sub: Intimation

 

This is to inform you that the audit of our Formulations Manufacturing facility at Shreveport, Louisiana, USA by the US FDA, has been completed on August 8, 2019. No Form 483 was issued at the end of the inspection.

 

This is for your information.

 

With regards,  
   
/s/ Sandeep Poddar  
Sandeep Poddar  
Company Secretary  

 

CC:- New York Stock Exchange Inc.(Stock Code :RDY)